In this context, researchers have identified 45 lncRNAs that are differentially expressed in NSCLC cells, which are resistant to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.